Skip to main content
Japanese Journal of Cancer Research : Gann logoLink to Japanese Journal of Cancer Research : Gann
. 2001 Oct;92(10):1057–1061. doi: 10.1111/j.1349-7006.2001.tb01060.x

Clinicopathological Characteristics of Estrogen Receptor‐(3‐positive Human Breast Cancers

Yasuo Miyoshi 1, Tetsuya Taguchi 1, Jan‐Åke Gustafsson 2, Shinzaburo Noguchi 1,
PMCID: PMC5926611  PMID: 11676856

Abstract

Recent studies have identified the presence of estrogen receptor (ER)‐β in addition to ER‐α in human breast cancers, but the Clinicopathological characteristics of ER‐β‐positive tumors remain to be established. In this study, we have conducted an immunohistochemical analysis of ER‐α and ER‐β expression in human breast cancers. In addition, we investigated the correlation of ER‐α and ER‐β expression with progesterone receptor (PR) status, determined by enzyme immunoassay, and with various Clinicopathological factors. Of 79 tumors, 49 (62%) were positive for ER‐α and 24 (30%) were positive for ER‐β, and there was no significant association between ER‐α and ER‐β expression. ER‐α‐positive tumors were significantly more likely to be PR‐positive than were ER‐α‐negative tumors (P<0.0001), but there was no significant association between ER‐β expression and PR status. However, the PR values of ER‐α‐positive and ER‐β ‐positive tumors (65±17 fmol/mg protein, mean±SE) were marginally significantly lower than those of ER‐α‐positive and ER‐β ‐negative tumors (340±109) (P=0.08). ER‐β positivity was significantly associated with small tumor size (<2 cm) and high histological grade (P<0.05), and this association was also observed when only ER‐α‐positive tumors were considered. These results suggest that determination of ER‐β status might be clinically useful for further defining the characteristics of ER‐α‐positive tumors

Keywords: ER‐α, ER‐β, PR, Immunohistochemical staining, Breast cancer

Full Text

The Full Text of this article is available as a PDF (815.6 KB).

REFERENCES

  • 1. ) Kuiper , G. G. , Enmark , E. , Pelto‐Huikko , M. , Nilsson , S. and Gustafsson , J. A.Cloning of a novel estrogen receptor expressed in rat prostate and ovary . Proc. Natl. Acad. Sci. USA , 93 , 5925 – 5930 ( 1996. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2. ) Walker , R. A.Oestrogen receptor and its potential role in breast cancer development . J. PathoL , 188 , 229 – 230 ( 1999. ). [DOI] [PubMed] [Google Scholar]
  • 3. ) Kuiper , G. G. , Carlsson , B. , Grandien , K. , Enmark , E. , Haggblad , J. , Nilsson , S. and Gustafsson , J. Å.Comparison of the ligand binding specificity and transcript tissue distribution of estrogen receptors α and β . Endocrinology , 138 , 863 – 870 ( 1997. ). [DOI] [PubMed] [Google Scholar]
  • 4. ) Watanabe , T. , Inoue , S. , Ogawa , S. , Ishii , Y. , Hiroi , H. , Ikeda , K. , Orimo , A. and Muramatsu , M.Antagonist effect of tamoxifen is dependent on cell type, ERE–promoter context, and estrogen receptor subtype: functional difference between estrogen receptors α and β . Biochem. Biophys. Res. Commun. , 236 , 140 – 145 ( 1997. ). [DOI] [PubMed] [Google Scholar]
  • 5. ) Paech , K. , Webb , P. , Kuiper , G. G. , Nilsson , S. , Gustafsson , J. A. , Kushner , P. J. and Scanlan , T. S.Differential ligand activation of estrogen receptors ER–α and β at API sites . Science , 277 , 1508 – 1510 ( 1997. ). [DOI] [PubMed] [Google Scholar]
  • 6. ) Cowley , S. M. , Hoare , S. , Mosselman , S. and Parker , M. G.Estrogen receptors α and β form heterodimers on DNA . J. Biol. Chem. , 272 , 19858 – 19862 ( 1997. ). [DOI] [PubMed] [Google Scholar]
  • 7. ) Pettersson , K. , Grandien , K. , Kuiper , G. G. and Gustafsson , J. A.Mouse estrogen receptor‐β forms estrogen response element binding heterodimers with estrogen receptor–α . Mol. Endocrinol , 11 , 1486 – 1496 ( 1997. ). [DOI] [PubMed] [Google Scholar]
  • 8. ) Dotzlaw , H. , Leygue , E. , Watson , P. H. and Murphy , L. C.Expression of estrogen receptor–β in human breast tumors . J. Clin. Endocrinol. Metab. , 82 , 2371 – 2374 ( 1997. ). [DOI] [PubMed] [Google Scholar]
  • 9. ) Speirs , V. , Parkes , A. T. , Kerin , M. J. , Walton , D. S. , Carleton , P. J. , Fox , J. N. and Atkin , S. L.Coexpression of estrogen receptor–α and –β: poor prognostic factors in human breast cancer ? Cancer Res. , 59 , 525 – 528 ( 1999. ). [PubMed] [Google Scholar]
  • 10. ) Speirs , V. , Malone , C. , Walton , D. S. , Kerin , M. J. and Atkin , S. L.Increased expression of estrogen receptor beta mRNA in tamoxifen–resistant breast cancer patients . Cancer Res. , 59 , 5421 – 5424 ( 1999. ). [PubMed] [Google Scholar]
  • 11. ) Iwao , K. , Miyoshi , Y. , Egawa , C. , Ikeda , N. , Tsukamoto , F. and Noguchi , S.Quantitative analysis of estrogen receptor–alpha and –beta messenger RNA expression in breast carcinoma by real–time polymerase chain reaction . Cancer , 89 , 1732 – 1738 ( 2000. ). [DOI] [PubMed] [Google Scholar]
  • 12. ) Roger , P. , Sahla , M. E. , Makela , S. , Gustafsson , J. Å. , Baldet , P. and Rochefort , H.Decreased expression of estrogen receptor β protein in proliferative preinvasive mammary tumors . Cancer Res. , 61 , 2537 – 2541 ( 2001. ). [PubMed] [Google Scholar]
  • 13. ) Järvinen , T. A. , Pelto–Huikko , M. , Holli , K. and Isola , J.Estrogen receptor beta is coexpressed with ER alph and PR and associated with nodal status, grade, and proliferation rate in breast cancer . Am. J. Pathol , 156 , 29 – 35 ( 2000. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14. ) Mann , S. , Laucirica , R. , Carlson , N. , Younes , P. S. , Ali , N. , Younes , A. , Li , Y. and Younes , M.Estrogen receptor beta expression in invasive breast cancer . Hum. Pathol , 32 , 113 – 118 ( 2001. ). [DOI] [PubMed] [Google Scholar]
  • 15. ) Saji , S. , Jensen , E. V. , Nilsson , S. , Rylander , T. , Warner , M. and Gustafsson , J. Å.Estrogen receptor α and β in the rodent mammary gland . Proc. Natl. Acad. Sci. USA , 97 , 337 – 342 ( 2000. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16. ) Leygue , E. , Dotzlaw , H. , Watson , P. H. and Murphy , L. C.Expression of estrogen receptor–beta 1, beta 2, and beta 5 messenger RNAs in human breast tissue . Cancer Res. , 59 , 1175 – 1179 ( 1999. ). [PubMed] [Google Scholar]
  • 17. ) Weihua , Z. , Saji , S. , Makinen , S. , Cheng , G. , Jensen , E. V. , Warner , M. and Gustafsson , J. A.Estrogen receptor (ER) beta, a modulator of ER alpha in the uterus . Proc. Natl. Acad. Sci. USA , 97 , 5936 – 5941 ( 2000. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18. ) Iwao , K. , Miyoshi , Y. , Egawa , T. , Ikeda , N. and Noguchi , S.Quantitative analysis of estrogen receptor–β mRNA and its variants in human breast cancers . Int. J. Cancer , 88 , 733 – 736 ( 2000. ). [DOI] [PubMed] [Google Scholar]

Articles from Japanese Journal of Cancer Research : Gann are provided here courtesy of Wiley

RESOURCES